Innovating Works

Lonza

Desconocido
FIGHT-HLH: First Targeted Therapy to FIGHT Hemophagocytic Lymphohistiocytosis HLH A novel approach to HLH LONZA BIOLOGICS PLC participó en un FP7: Hemophagocytic lymphohistiocytosis (HLH) is a rare, devastating disease characterized by uncontrolled immune response that primarily affects...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.